González-González C, Arvilla-Arce HE

Language: Spanish
References: 13
Page: 59-64
PDF size: 203.37 Kb.

ABSTRACT

The recent COVID-19 has had an impact on the lifestyle of everyone. Initially, health care system prioritized the pulmonary distress as the key feature of the pandemic, being the highest mortality indicator. However, we know today the multiple repercussions found on various organs and systems, including the Central Nervous System. We are addressing neuropsychiatric symptoms both during acute and recovery phase of COVID-19.
Inflammatory distress on the Central Nervous System caused due to cytokines would explain the establishment of both functional and structural damage and the subsequent development of neuropsychiatric symptoms; likewise, this inflammatory process is similar to the one seen on other primary psychiatric disorders.
There have been several clinical trials that have documented the presence of depression, anxiety, posttraumatic stress disorder, delirium, psychosis and neurocognitive disorders on patients with COVID-19, both during acute and recovery phase. Being aware of this outcome will be useful on managing these disorders and possibly prevent the aft ermath on patients during the recovery phase of COVID-19.
The present article is an attempt on providing a broader overview on the neuropsychiatric complications on patients with COVID-19 found across various studies conducted worldwide.

REFERENCES

1. Rodríguez-Quiroga A, Buiza C, Álvarez de Mon y Quintero J. COVID-19 y salud mental. Medicine 2020; 13 (23): 1285-1296.

2. Hu Y, Chen Y, Zhen Y, You C, Taqn Y, Hu L, et al. Factors related to mental health of inpatients with COVID-19 in Wuhan, China. Brain, behavior, and immunity 2020; 89: 587-593.

3. Liu D, Baumeister R, Veileux J, Cheng C, Liu W, Yue Y, et al. Risk factors associated with mental illness in hospital discharged patients infected with COVID-19 in Wuhan, China. Psychiatry research 2020; 292: 113297.

4. Raony Í, de Figueiredo CS, Pandolfo P, Giestal-de-Araujo E, Oliveira-Silva Bomfi m P, & Savino W. (2020). Psychoneuroendocrine- immune interactions in COVID-19: potential impacts on mental health. Frontiers in Immunology 2020; 11:1170.

5. Sadock BJ, Sadock VA and Ruiz P: Kaplan & Sadock Manual de psiquiatría clínica. Wolters Kluwer, 2018.

6. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub, 2013.

7. Varatharaj A, Th omas N, Ellul MA, Davies NWS, Pollack TA, Tenorio E. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Th e Lancet Psychiatry 2020; 7 (10): 875-882.

8. Liguori C, Pierantozzi M, Spanetta M, Sarmati L, Cesta N, Lanetta M, et al. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection. Brain, behavior, and immunity 2020; 88: 11-16.

9. Rogers J, Chesney E, Oliver D, Pollak T, McGuire P, Fusar- Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Th e Lancet Psychiatry 2020; 7 (7): 611-627.

10. Zhang J, Zeng H, Zhang S, Du Q, Jian T et al. Th e diff erential psychological distress of populations aff ected by the COVID-19 pandemic. Brain, behavior, and immunity 2020; 87:49-50.

11. Krishnamoorthy Y, Nagarajan R, Saya GK & Menon V. Prevalence of psychological morbidities among general population, healthcare workers and COVID-19 patients amidst the COVID-19 pandemic: A systematic review and metaanalysis. Psychiatry research 2020; 293: 113382.

12. Guo Q, Zheng Y, Shi J, Wang J, Li G, Li C, et. al. Immediate psychological distress in quarantined patients with COVID-19 and its association with peripheral infl ammation: a mixedmethod study. Brain, behavior, and immunity 2020; 88:17-27.

13. González-González C. Actualidades en la fi siopatología del trastorno por estrés postraumático (TEPT). Salud Jalisco 2018; 1 (2): 128-134.